Ospedale Sant'Anna - ASST LARIANA
- Address
- Via Ravona, 20 - 22042 San Fermo della Battaglia (CO), 22042 San Fermo della Battaglia, Italy
Ospedale Sant'Anna - ASST LARIANA
Ospedale Sant'Anna, part of ASST LARIANA, is actively engaged in advanced oncology research with a particular emphasis on breast cancer treatment strategies. The center specializes in investigating novel therapeutic approaches for patients with hormone receptor positive cancers who have experienced disease progression on standard treatments.
- Advanced breast cancer treatment in hormone receptor positive (HR+) and HER2-negative patients
- Sequential therapy strategies following CDK4/6 inhibitor failure
- Combination regimens with palbociclib and fulvestrant in metastatic settings
The research center focuses on addressing critical challenges in locally advanced or metastatic breast cancer management, particularly in women whose disease has progressed after first-line CDK4/6 inhibitor therapy combined with hormonal treatment. Their clinical trial portfolio demonstrates expertise in evaluating both efficacy and safety outcomes for patients requiring second-line therapeutic interventions in the adjuvant and metastatic settings.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Consorzio Oncotech1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ospedale Sant'Anna - ASST LARIANA
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Palbociclib and Fulvestrant in HR+/HER2- Advanced Breast Cancer Post-CDK4/6 Inhibitor Therapy: A Phase II Multicenter Study | Consorzio Oncotech | Phase II | Recruiting | Oct 2019 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Palbociclib | 1 | Unknown | 2019-10-18 | 2019-10-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.